Found 4499 articles for: "melasma"
The Efficacy of Intense Pulsed Light and Laser Hair Removal in Hidradenitis Suppurativa Treatment
November 2024 | Volume 23 | Issue 11 | Original Article | 926 | Copyright © November 2024
Background: Hidradenitis suppurativa (HS) is a multifactorial disease that presents with chronic cycles of inflammation, healing, and scarring and that elicits a profoundly negat...
Read MoreClindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey
November 2024 | Volume 23 | Issue 11 | Case Reports | 1017 | Copyright © November 2024
Introduction: Topical clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel is the only fixed-dose, triple-combination formulation approved for acne treatmen...
Read MoreFULL SUPPLEMENT: Topical Acne Treatment: What's Behind the Scenes in 2024
November 2024 | Volume 23 | Issue 11 | Department | 46941s1 | Copyright © November 2024
Optimal topical acne treatments should ideally target multiple pathways involved in acne development.2 Traditional treatments, though often effective, may come with limitations such as skin irri...
Read MoreINDIVIDUAL ARTICLE: VEHICLES ALWAYS MATTER
November 2024 | Volume 23 | Issue 11 | Supplement Individual Articles | 46941s3 | Copyright © November 2024
Over the past several years, the field of acne treatments, which had been relatively unchanged, has welcomed a variety of innovations. From new molecules and mechanisms of action to previously implaus...
Read MoreINDIVIDUAL ARTICLE: All for One and One for All: The Three Musketeers of Topical Acne Treatment and the Current Landscape
November 2024 | Volume 23 | Issue 11 | Supplement Individual Articles | .46942s4 | Copyright © November 2024
What is the ideal topical acne therapeutic? Topical therapeutics for acne vulgaris have advanced considerably over the last decade. Novel vehicular technologies have increased transdermal penetra...
Read MoreFULL SUPPLEMENT: Real-World Clinical Experience Combining A Neuro-Peptide Serum And Botulinum Toxin Type-A Injections
November 2024 | Volume 23 | Issue 11 | Department | 43661s1 | Copyright © November 2024
By 2050, the World Health Organization (WHO) estimates that the world's population of people aged 65 years and older will have more than doubled from 761 million in 2021. As the population and their s...
Read MoreINDIVIDUAL ARTICLE: Real-World Clinical Experience With a Neuro-Peptide Serum in Combination With Botulinum Toxin Type-A Injections
November 2024 | Volume 23 | Issue 11 | Supplement Individual Articles | 43661s3 | Copyright © November 2024
We evaluated real-life experiences of a topical neuro-peptide serum containing 2% acetyl hexapeptide-8, 2% dipeptide diaminobutyroyl, 5% polyhydroxy acids (PHA), 5% niacinamide, and 1% laminaria ...
Read MoreGLP-1 Receptor Agonists for the Dermatologist: Uses and Considerations
November 2024 | Volume 23 | Issue 11 | Features | 1026 | Copyright © November 2024
New Formulations of Acyclothymidine Dinucleosides Reduce Damaging Effects of Ultraviolet Radiation in an Ex Vivo Skin Model
November 2024 | Volume 23 | Issue 11 | Original Article | 953 | Copyright © November 2024
The greatest risk factor for skin cancer is exposure to ultraviolet (UV) rays of the sun. Among the three types of solar radiation (UVA, UVB, UVC), UVB rays are most commonly associated with skin...
Read MoreTreatment of Mild to Severe Acne Vulgaris With a 650-Microsecond 1064-nm Nd:YAG Laser
November 2024 | Volume 23 | Issue 11 | Original Article | 957 | Copyright © November 2024
Background: Effective treatment of acne remains a challenge to dermatologists.Objective: To evaluate the efficacy and tolerability of a 650-microsec...
Read MoreAttitudes on, Practices, and Recommendations for Visible Light Protection Amongst Dermatology Practitioners
November 2024 | Volume 23 | Issue 11 | Original Article | 965 | Copyright © November 2024
Background: Iron oxides, antioxidants, and pigmentary titanium dioxide are sunscreen additive ingredients that enhance visible light protection, reduce associated hyperpigme...
Read MoreThe Clinical Efficacy and Tolerability of a Novel Retinaldehyde Serum with Firming Peptides to Improve Skin Texture and Signs of Photoaging
November 2024 | Volume 23 | Issue 11 | Original Article | 992 | Copyright © November 2024
Retinoids are derivatives of vitamin A prominently used in cosmeceuticals to reverse signs of photoaging. Retinaldehyde (retinal) is 10x more bioavailable than retinol and is gaining tra...
Read MoreIsobutylamido Thiazolyl Resorcinol (Thiamidol) for Combatting Hyperpigmentation: A Systematic Review of Clinical Studies
November 2024 | Volume 23 | Issue 11 | Original Article | 986 | Copyright © November 2024
Background: Tyrosinase is the rate-limiting enzyme of melanogenesis and thus an ideal inhibitory target for treating hyperpigmentation. There are many commercially available tyro...
Read MoreCritical Insights on Preparation of Platelet-Rich Plasma in Tubes With a Thixotropic Gel Separator
November 2024 | Volume 23 | Issue 11 | Original Article | 979 | Copyright © November 2024
Thixotropic gels are the preferred choice in the collection of platelet-rich plasma as an easy solution to operator variability. One often unnoticed shortcoming is the entrapment of platelets in ...
Read MoreSafety and Effectiveness of Synchronized Monopolar Radiofrequency and HIFES in Patients Injected With Botulinum Toxin
November 2024 | Volume 23 | Issue 11 | Original Article | 937 | Copyright © November 2024
Background: Botulinum toxin (BT) has become one of the most frequently sought aesthetic procedures for wrinkle reduction.Objective: This study inves...
Read MoreEfficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia
November 2024 | Volume 23 | Issue 11 | Original Article | 1003 | Copyright © November 2024
Background: Androgenetic Alopecia (AGA) (male pattern hair loss) is the most common form of alopecia in men, affecting 30% of men by the age of 30 years and 50% by the age of 50 ...
Read MoreBiologic Use During Pregnancy and Breastfeeding in Dermatology: An Evidence-Based Review
November 2024 | Volume 23 | Issue 11 | Original Article | 1010 | Copyright © November 2024
Biologic medications have revolutionized the treatment of many dermatologic conditions. However, their use during pregnancy and breastfeeding is a subject of ongoing concern due to limited data o...
Read MoreA Single-Center, Open-Label, Prospective Study of a 589/1319 nm Dual Wavelength Laser for the Treatment of Facial Hyperpigmentation
November 2024 | Volume 23 | Issue 11 | Original Article | 943 | Copyright © November 2024
Background: Facial hyperpigmentation, characterized by the excessive production of melanin in the skin, is a prevalent dermatological concern affecting individuals of various eth...
Read MoreFrom CO2 to Er:YAG: A Comprehensive Review of Laser Treatments for Rhinophyma
November 2024 | Volume 23 | Issue 11 | Original Article | 932 | Copyright © November 2024
Background: Rhinophyma, a benign condition resulting in nasal sebaceous tissue hypertrophy, predominantly affects Caucasian males. There are numerous surgical and medical treatme...
Read MoreA Review of Energy-Based Device Interventions to Treat Keloid Scars
November 2024 | Volume 23 | Issue 11 | Original Article | 998 | Copyright © November 2024
Media and other results for: "melasma"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
